Most JAPFA-favourable MENA agency regime

🇲🇦 Morocco

1 signed agreement (CASAVET S.A.R.L.). Variant supply-agreement template — not the standard Vaksindo distribution template. Key term-length ambiguity between body and price exhibit needs clarification.

Country profile

Morocco — regulatory context

Commercial agency law
Law 17-02 on Commercial Agency (2002, amended 2025). NO mandatory compensation (Article 15) — discretionary damages only on bad faith. Register with Commercial Registry (OMPIC) within 30 days; non-registration voids exclusivity (Article 7). Most JAPFA-favorable agency regime in MENA.
Vet drug authority
ONSSA (Office National de Sécurité Sanitaire des Produits Alimentaires). ONSSA e-portal for registration. Sanitary/phytosanitary approvals (high-risk products only). GMP certificate; Free Sale Certificate optional. Timeline: 6-12 months.
FX rules
Office des Changes Circular 03/2025 — free repatriation for exports. Pharma distributors limited to 40% local sourcing requirement. Digital notifications.
Multi-distributor permissibility
YES Morocco Law 17-02 (amended 2025) does not require single/exclusive OMPIC registration per product line; multiple distributors permitted unless contractually exclusive. NO mandatory compensation (Article 15) — most JAPFA-favorable MENA regime for multi-distributor strategy.
Voidance risks
  • Language law: Arabic required for state courts (per Dahir on Obligations and Contracts); French commonly accepted in commercial chambers; foreign-language contracts require certified Arabic translation.
  • Commercial registry filing: OMPIC registration within 30 days — non-registration voids exclusivity (Article 7 of Law 17-02), but contract still enforceable as non-exclusive distribution.
  • Stamp duty: Timbres fiscaux 1-3% based on value; non-affixation weakens enforceability.
  • Notarization / apostille: Optional but recommended for higher-value agencies; Morocco is Hague Apostille member.
  • No mandatory compensation: Article 15 — discretionary damages only on bad faith. JAPFA-friendly.
JAPFA recommendation
Strong jurisdiction for distributor structuring. Standard distribution agreement should work without modification. Comfortable jurisdiction to appoint multiple distributors.
Signed contracts in this country

CASAVET S.A.R.L. — supply-agreement variant

Counterparty
CASAVET S.A.R.L.
Effective
30 April 2023
Term
5 years (body) vs 3 years (price exhibit) — ambiguous
Score / grade
66 / 100C
Template
Variant Supply Agreement (12 pages) — not Standard Vaksindo Distribution Agreement

Top 3 issues

  1. Different template family (Supply Agreement, 12 pages).
  2. Missing governing law statement — single SIAC forum only, no explicit Indonesian law.
  3. Term-length ambiguity (5y body vs 3y price exhibit).

Authorized Products (current LOA)

Source: Exhibit A of signed Supply Agreement (no standalone LOA; Morocco model uses CASAVET-held MA at ONSSA with dossier provided by Vaksindo). 12 SKUs authorized.

#ProductStrainDoseY1 / Y2 / Y3 minUSD
1Vaksimune NDL H9ND Lasota + H9 AI1000 DS5,000 / 10,000 / 30,00025.52
2Vaksimune IBD MHvIBD MH variant1000 DS10,000 / 30,000 / 40,0004.60
3Vaksimune IBH DuoIBH Duo1000 DS1,500 / 3,000 / 5,00025.32
4Vaksimune NDL IBH DuoND Lasota + IBH Duo1000 DS0 / 500 / 1,00028.32
5Plus 8 additional SKUs in Exhibit A — ND Clone, ND Clone IB, IBD L, ILT, Coryza LE, NDL Multi Inaktif, AI Multi, etc.See full Exhibit A in signed PDF

Years 4-5 minimums UNDEFINED in Exhibit B — gap. Resolve at next amendment touch.

Suggested actions next touch
Open items
  1. Clarify term length — 5 years body vs 3 years price exhibit.
  2. Address MA-language hybrid (Marketing Authorisation throughout).
  3. Limit Vaksindo's right to alter SPECIFICATIONS post-effective (Art. 8.2).
  4. Add Indonesian governing-law statement (currently only single SIAC forum).
Drafts in progress

No drafts in progress for Morocco

Marketing agreements

No marketing agreements indexed